Avricore Health (AVCRF) Cost of Revenue (2009 - 2026)

Avricore Health (AVCRF) has reported Cost of Revenue for 16 consecutive years, with $38239.1 the latest figure, recorded in Q2 2026.

• In Q2 2026, Cost of Revenue fell 31.0% year-over-year to $38239.1; the TTM figure through Jun 2026 stood at $127388.4 (down 92.28% YoY), while the FY2025 annual figure was $211559.4, down 90.03% from the prior year.
• Cost of Revenue climbed to $38239.1 in Q2 2026 per AVCRF's latest filing, from $9463.6 in the prior quarter.
• Across five years, Cost of Revenue topped out at $1.5 million in Q3 2024 and bottomed at $7018.2 in Q4 2024.
• Historically, Cost of Revenue has averaged $327609.9 across 5 years, with a median of $165369.4 in 2023.
• Annual changes were most pronounced in 2022 — Cost of Revenue jumped 2801.41% — and 2024, when it tumbled 98.88%.
• Avricore Health's Cost of Revenue stood at $595543.3 in 2022, then advanced by 5.2% to $626512.5 in 2023, then sank by 98.88% to $7018.2 in 2024, then soared by 100.69% to $14085.0 in 2025, then soared by 171.49% to $38239.1 in 2026.
• Business Quant data shows AVCRF's Cost of Revenue at $38239.1 in Q2 2026, $9463.6 in Q1 2026, and $14085.0 in Q4 2025.